Structured evidence table for Green Tea Weight Loss Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Green Tea Weight Loss Randomized Trial | 2021 2023 2021 2019 2021 2018 Excess body weight is defined as a chronic and multifactorial condition associated with the development of morbidities associated with the accumulation of body fat (Tchang et al.). | 2 | Bonifácio Dandara Baia (2026) | Effect of Green Tea Kombucha Within an Energy‐Restricted Diet on Cardiometabolic Risk Markers in Individuals With Excess Body Weight: A Randomized Controlled Trial |
| Green Tea Weight Loss Randomized Trial | The accumulation of body fat is characterized as a risk factor for the development of cardiovascular diseases through the possibility of the coexistence of insulin resistance, hyperglycemia, hypertension, and dyslipidemia (Bovolini et al.). | 2 | Bonifácio Dandara Baia (2026) | Effect of Green Tea Kombucha Within an Energy‐Restricted Diet on Cardiometabolic Risk Markers in Individuals With Excess Body Weight: A Randomized Controlled Trial |
| Green Tea Weight Loss Randomized Trial | For these reasons, people with excess body weight have a higher risk of death from cardiovascular diseases, independent of other metabolic factors (Powell‐Wiley et al.). | 2 | Bonifácio Dandara Baia (2026) | Effect of Green Tea Kombucha Within an Energy‐Restricted Diet on Cardiometabolic Risk Markers in Individuals With Excess Body Weight: A Randomized Controlled Trial |
| Green Tea Weight Loss Randomized Trial | In the European region, 60% of adults have excess weight, which has been one of the main determinants of disability and death (The Lancet Public Health). | 2 | Bonifácio Dandara Baia (2026) | Effect of Green Tea Kombucha Within an Energy‐Restricted Diet on Cardiometabolic Risk Markers in Individuals With Excess Body Weight: A Randomized Controlled Trial |
| Green Tea Weight Loss Randomized Trial | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Gelidium Garcinia cambogia The World Health Organization defines overweight and obesity as abnormal or excessive fat accumulation that presents health risk to health []. | 4 | Lee Hyeonseok (2026) | Consumer Perceptions Influence Supplement Choice: A Narrative Review of Clinically Studied Weight-Management Supplements in Obesity |
| Green Tea Weight Loss Randomized Trial | The prevalence of obesity in South Korea has steadily increased over the past decade, reaching approximately 38% in 2022, although the prevalence of severe obesity (body mass index [BMI] ≥ 40 kg/m) increased by 2.6-fold when compared with that in 2013 []. | 4 | Lee Hyeonseok (2026) | Consumer Perceptions Influence Supplement Choice: A Narrative Review of Clinically Studied Weight-Management Supplements in Obesity |
| Green Tea Weight Loss Randomized Trial | This condition induces insulin resistance and hyperinsulinemia, leading to metabolic disorders and markedly increasing the risk of various chronic diseases including type 2 diabetes, cardiovascular disease, multiple types of cancer, and depression. | 4 | Lee Hyeonseok (2026) | Consumer Perceptions Influence Supplement Choice: A Narrative Review of Clinically Studied Weight-Management Supplements in Obesity |
| Green Tea Weight Loss Randomized Trial | Obesity has become a global epidemic, and its severity is progressively increasing []. | 4 | Lee Hyeonseok (2026) | Consumer Perceptions Influence Supplement Choice: A Narrative Review of Clinically Studied Weight-Management Supplements in Obesity |
Source documents